What blocks vitamin C absorption?

Take more than a gram of vitamin C a day and your body absorbs less than half of it.

That is not a manufacturing flaw or a quality problem. It is how the gut is built. The transporters that carry vitamin C across the intestinal wall are saturable, and once they are full, extra milligrams mostly pass through.

Roughly 41.8% of US adults sit below adequate vitamin C status. For most of them, the problem is intake. For people already taking gram doses, the question is different: why a bigger dose barely moves the needle.

Table of Contents

1. How Vitamin C Actually Crosses the Gut Wall
2. The Saturation Ceiling: What Happens as the Dose Climbs
3. Where the Rest Goes: Plasma Plateau and Renal Clearance
4. What Else Blocks Vitamin C Absorption Besides Dose Size
5. Getting More From the Same Milligrams
6. Why Delivery Format Changes the Route
7. Bio Absorb Nutraceuticals' Liposomal Vitamin C
8. Frequently Asked Questions
9. Conclusion
10. Research References

1. How Vitamin C Actually Crosses the Gut Wall

Vitamin C does not simply soak through the intestine. It is carried across by a dedicated protein called SVCT1 — sodium-dependent vitamin C transporter 1 — sitting in the brush border membrane of intestinal cells. Intestinal absorption occurs through a sodium-dependent active transport process that is saturable and dose dependent, with simple diffusion taking over only at high gut concentrations.

Researchers mapped the structure of this transporter in detail in 2023, using cryo-electron microscopy to capture mouse SVCT1 in both its empty and substrate-bound states. The picture that emerged is of a machine with a fixed cycle time: it binds vitamin C, moves it, resets, repeats. There is a maximum rate, and no amount of extra substrate raises it.

That single fact drives almost everything else in this article. A 90mg intake and a 2,000mg intake are handled by the same finite set of transporters. The first is comfortably within capacity. The second is not, which is why the total body pool tops out between roughly 300mg near scurvy and about 2 grams when replete no matter how much you swallow.

2. The Saturation Ceiling: What Happens as the Dose Climbs

The dose–absorption relationship is not a straight line, and the drop-off is steeper than most labels suggest. The NIH reports that approximately 70% to 90% of vitamin C is absorbed at moderate intakes of 30 to 180mg per day, falling to less than 50% at doses above 1 gram, with absorbed but unused vitamin C excreted unchanged in urine.

The foundational data comes from a 1996 depletion–repletion study in which seven volunteers were hospitalised for four to six months on a diet containing under 5mg of vitamin C daily, then given escalating doses. Bioavailability was complete for a single 200mg dose, and at single doses of 500mg and higher it declined while the absorbed surplus went straight to urine. Six of the seven volunteers excreted no vitamin C at all until the 100mg dose.

Translated into the doses people actually buy:

• At 200mg in one dose, absorption is effectively complete
• From 500mg upward, an increasing share is absorbed and then excreted
• Above 1,000mg a day, less than half is absorbed at all
• Dietary intakes of 30–180mg sit in the 70–90% band — the efficient zone

A 1,000mg tablet is therefore not a 1,000mg delivery. At that dose, absorption efficiency is already falling, and the unabsorbed share keeps growing as the dose climbs. The practical implications for choosing a daily amount are covered in our guide to vitamin C dosage and how much to take per day.

3. Where the Rest Goes: Plasma Plateau and Renal Clearance

Absorption is only the first gate. The second is the kidney, which defends a tightly controlled blood level and dumps the excess. The Linus Pauling Institute describes plasma reaching steady state at 60–80 µmol/L on intakes of 200–400mg a day in healthy young adults — and staying there.

Raising the dose far beyond that moves the number surprisingly little. Pharmacokinetic work cited by the NIH found that 1.25g a day produces mean peak plasma concentrations of about 135 µmol/L, and modelling predicts even 3g every four hours would reach only 220 µmol/L. That is roughly a 14-fold increase in daily intake buying well under a 2-fold increase in peak blood level.

The same transporter family polices the exit. A 2019 review of vitamin C pharmacokinetics notes that SVCT1 governs renal reuptake as well as intestinal uptake, and that once plasma is saturated, excretion of surplus vitamin C is quantitative — essentially all of it leaves. Two saturable gates in series is the reason the ceiling is so firm.

Only one route sidesteps the first gate entirely. Intravenous administration bypasses the intestine, which is why it reaches plasma concentrations oral dosing cannot approach at any practical dose — a separate question from everyday supplementation, covered in how IV vitamin C compares with oral and liposomal.

4. What Else Blocks Vitamin C Absorption Besides Dose Size

Dose size is the largest single factor, but it is not the only one. Sustained high intake appears to turn the transporters down: a study in human intestinal epithelial cells found SVCT1 expression fell by 77% after 24 hours of exposure to elevated ascorbate. The authors' conclusion was blunt — high-dose supplements may not be the most efficient way to raise the body pool.

Several other factors shift the arithmetic, though they act on requirement and status as much as on absorption itself:

• Smoking. Oxidative turnover runs higher, which is why the DRI adds 35mg a day to the requirement for smokers. NHANES found 60.8% of smokers below sufficiency against 34.8% of non-smokers.
• Gastrointestinal conditions. Anything that reduces functioning absorptive surface — inflammatory bowel disease, coeliac disease, bowel resection — can reduce uptake, and the NIH lists people with severe intestinal malabsorption among those at higher risk of inadequate vitamin C.
• Who falls short. The 41.8% insufficiency figure in the 2003–2006 NHANES analysis was concentrated in specific groups: men, adults under 60, smokers, people with a higher BMI, lower- and middle-income households, and people facing food insecurity. The analysis graded plasma levels from deficiency below 11 µmol/L to saturating at 70 µmol/L and above.

One popular belief does not survive contact with the data. Food-versus-supplement source is not an absorption variable: the bioavailabilities of vitamin C from foods and from supplements are not significantly different, and the type of food consumed has not been shown to matter much either. An orange and a tablet at the same milligram load behave alike. What differs is the dose per sitting — food rarely delivers 1,000mg at once.

5. Getting More From the Same Milligrams

The saturation curve cuts both ways. The Linus Pauling Institute notes that up to 200mg taken at a time is absorbed completely, while doses above 500mg are absorbed fractionally less as the dose rises. Splitting the same daily total into smaller doses therefore recovers a meaningful share of what a single large dose would lose.

Three adjustments follow from the pharmacology rather than from habit:

• Split larger totals. Anything above roughly 500mg a day is a candidate, because that is where the 1996 data shows bioavailability beginning to fall.
• Stop chasing the plateau. Past 400mg a day, plasma is already sitting near its 60–80 µmol/L ceiling and further increases buy very little.
• Watch tolerance, not just absorption. The 2,000mg upper intake level for adults was set to avoid diarrhoea and gastrointestinal upset, and unabsorbed vitamin C in the bowel is part of that mechanism.

Consistency outperforms size. Because the body pool caps out near 2 grams and the kidney clears the surplus daily, a modest dose taken reliably keeps status higher than a large dose taken occasionally. The megadose case is examined separately in high-dose vitamin C.

6. Why Delivery Format Changes the Route

Every constraint above applies to standard ascorbic acid moving through SVCT1. Liposomal delivery encapsulates vitamin C inside a phospholipid shell, which is taken up by a different mechanism — one that is not competing for the same saturable transporter at supplemental doses. The question is how much difference that makes in practice.

The most complete answer comes from a 2025 scoping review that screened 321 studies and analysed the 10 that directly compared liposomal with non-liposomal vitamin C. Nine of the 10 showed higher plasma bioavailability, with Cmax 1.2–5.4-fold higher and AUC 1.3–7.2-fold higher across doses ranging from 0.15g to 10g. Two recent double-blind trials sit at the low end of that spread: a 2024 crossover trial in 27 adults at 500mg reported plasma Cmax 27% higher and leukocyte Cmax 20% higher for the liposomal form, while a 2024 trial in 10 adults at 1,000mg found a 30% AUC increase and a 30% higher blood level at the 24-hour mark.

The honest framing matters more than the headline. The range is wide because formulations, particle sizes and doses differ. None of the 10 studies measured excretion, so it is not yet clear how much of the extra vitamin C the body keeps, and only two assessed any biological effect at all. Both of the trials above also had industry-affiliated authors. The absorption advantage is consistently documented; whether it produces better clinical outcomes in people who are already replete has not been established. Better absorption is a reason a given dose may travel further, not a reason to expect a different result.

How the two formats compare head to head is covered in liposomal vitamin C vs regular vitamin C, and the wider question of ascorbic acid against buffered and Ester-C in vitamin C forms compared. Background on the delivery system itself is in our complete guide to liposomal vitamin C.

7. Bio Absorb Nutraceuticals' Liposomal Vitamin C

Bio Absorb Nutraceuticals makes its Liposomal Vitamin C in a GMP-certified Canadian facility, in two formats built on the same formulation. The Liposomal Vitamin C Liquid mixes with water or juice and has a natural orange flavour; the Liposomal Vitamin C Capsules need no refrigeration and travel well.

Given everything above, format is a practical decision rather than a quality one. The liquid allows finer adjustment when you are splitting a total across the day — which the saturation data suggests is worth doing above roughly 500mg. The capsules are easier to keep consistent, and consistency is what actually holds status near that 60–80 µmol/L plateau.

Both are verified corn-free, which is unusual in a category where most ascorbic acid is corn-derived. For most people that is irrelevant; for anyone with a corn allergy or sensitivity it is often the difference between tolerating a daily supplement and abandoning one. Both are also non-GMO, gluten-free, nut-free, dairy-free and vegan, non-irradiated, and third-party tested every batch, so the label and the independent result describe the same product. Both are covered by a money-back guarantee.

See current pricing and serving details for the liquid or the full product specification for the capsules.

Frequently Asked Questions

Does taking vitamin C with food improve absorption?

Not meaningfully. Vitamin C is water-soluble and needs no dietary fat, and the DRI review found no significant difference between food and supplement bioavailability. Food can help with comfort, though: taking larger doses with a meal may ease the stomach upset some people notice.

Is a 1,000mg tablet wasted?

Not wasted, but not fully used: absorption falls below 50% above 1 gram a day, and what is absorbed beyond the plasma ceiling is excreted. Splitting the same 1,000mg into two or more smaller doses recovers part of the difference.

Why does my urine turn bright yellow after vitamin C?

That is usually riboflavin from a multivitamin rather than vitamin C, but the underlying principle holds — once plasma is saturated, surplus vitamin C is excreted quantitatively. Visible colour is not a reliable gauge of how much you absorbed.

Do I absorb vitamin C less well as I get older?

There is no clear sign of it in the national data. In the NHANES analysis, adults 60 and over had the best vitamin C status of any age group, with 40% at saturating levels against about 22% of younger adults. Intake, smoking and conditions that reduce absorptive gut surface matter more than age itself.

Does liposomal vitamin C bypass the absorption ceiling completely?

It changes the route rather than removing every limit. The 1.3–7.2-fold AUC range reported across 9 of 10 trials is wide and describes blood exposure, not clinical effect. Treat it as a reason a given dose may go further, not as a fixed conversion factor.

Who should be cautious about pushing the dose up?

The tolerable upper intake level for adults is 2,000mg a day. Anyone with kidney disease, a history of kidney stones, or haemochromatosis or another iron-overload condition should discuss supplemental vitamin C with a physician before going near that level. Anyone on regular medication should check with their doctor first too: the NIH notes that vitamin C supplements may interact with some chemotherapy drugs, radiation therapy and statins.

Conclusion

Vitamin C absorption is governed by a saturable transporter and a kidney that defends a fixed blood level, which is why less than half is absorbed once intake passes a gram a day. The lever that matters is not the number on the label but how the dose is split and how it is delivered. If you want yours to travel further, see current pricing and serving details for Bio Absorb's Liposomal Vitamin C.

Research References

1. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences, Vol. 93, No. 8 (1996), pp. 3704–3709. Depletion–repletion study in seven hospitalised volunteers establishing complete bioavailability at a single 200mg dose, declining bioavailability from 500mg upward, and no urinary excretion in six of seven volunteers until the 100mg dose.
2. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, No. 1 (2025), article e70067. Screened 321 studies and analysed 10; 9 showed higher plasma bioavailability for liposomal vitamin C, with Cmax 1.2–5.4-fold and AUC 1.3–7.2-fold higher, while noting that none of the studies measured excretion and only two assessed any biological effect.
3. Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. European Journal of Nutrition, Vol. 63, No. 8 (2024), pp. 3037–3046. Crossover trial in 27 adults at a 500mg dose finding plasma Cmax 27% higher and leukocyte Cmax 20% higher for the liposomal form.
4. Bioavailability of Liposomal Vitamin C in Powder Form: A Randomized, Double-Blind, Cross-Over Trial. Applied Sciences, Vol. 14, No. 17 (2024), article 7718. Single-dose crossover trial in 10 healthy adults at 1,000mg reporting a 30% increase in AUC and a 30% increase in concentration at 24 hours versus non-encapsulated vitamin C.
5. Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line. British Journal of Nutrition, Vol. 87, No. 2 (2002), pp. 97–100. Found SVCT1 expression reduced by 77% after 24 hours of exposure to elevated ascorbate, suggesting high-dose supplements are not the most efficient route to raising the body pool.
6. The Pharmacokinetics of Vitamin C. Nutrients, Vol. 11, No. 10 (2019), article 2412. Review establishing the role of SVCT1 in both intestinal uptake and renal reuptake, and that excretion of surplus vitamin C is quantitative once plasma is saturated.
7. Insufficient Vitamin C Levels among Adults in the United States: Results from the NHANES Surveys, 2003–2006. Nutrients, Vol. 13, No. 11 (2021), article 3910. Cross-sectional analysis finding 41.8% of US adults at insufficient plasma vitamin C levels, with smokers among the groups significantly associated with insufficiency.
8. Structural basis of vitamin C recognition and transport by mammalian SVCT1 transporter. Nature Communications, Vol. 14 (2023), article 1361. Cryo-EM structures of mouse SVCT1 in apo and substrate-bound states, revealing the structural basis of substrate recognition and the transport cycle.
9. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids — Vitamin C chapter. Institute of Medicine, National Academies Press (2000). Source for saturable sodium-dependent active transport, 70–90% absorption at 30–180mg/day falling to about 50% or less above 1g, the 35mg/day smoker increment, and the finding that food and supplement bioavailability do not differ significantly.
10. Vitamin C — Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements (2025). Source for absorption of 70–90% at 30–180mg/day falling below 50% above 1g/day, peak plasma of 135 µmol/L at 1.25g/day, the 220 µmol/L modelled ceiling, and total body pool of 300mg to 2g.
11. Vitamin C — Micronutrient Information Center. Linus Pauling Institute, Oregon State University. Source for plasma steady state of 60–80 µmol/L at intakes of 200–400mg/day in healthy young adults.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.